1Karim AB,Afra D,Cornu P,et al.Randomized trial on the efficacy of radiotherapy for low-grade glioma in the adult:European Orgnization for Research and Treatment of Cancer Study 22845 with the Medical Research Council Study BRO4-an interim analysis[J].Int J Radiat Oncol Biol Phys,2002,52(2):316-324.
2Glioma Meta-analysis Trialists(GMT) Group.Chemotherapy in adult high-grade glioma:a systemic review and metaanalysis of individual patient data from 12 randomized trial[J].Lancet,2002,359(9311):1011-1018.
3Yung WK,Prados MD,Yaya-Tur R,et al.Multicenter phase Ⅱ trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse:Temodal Brain Tumor Group[J].J Clin Oncol,1999,17(9):2762-2771.
4Brandes AA,Turazzi S,Basso U,et al.A multidrug combination designed for reversing resistance to BCNU in glioblastoma multiforme[J].Neurology,2002,58 (12):1759-1764.
5Athanassiou H,Synodinou M,Maragoudakis E,et al.Randomized phase Ⅱ study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme[J].J Clin Oncol,2005,23:2372-2377.
6Stupp R,Mason WP,Van Den Bent Mj,et al.Concomitant and adjuvant temozolomide(TMZ) and radiothrerapy(RT) for newly diagnosed glioblastoma multiforme(GBM):conclusive results of a randomized phase Ⅲ trial by EORTC Brain &RT Group and NCIC Clinical Trial Group[J].J Clin Oncol,2004,22 (suppl 145):2.
7Stupp R,Mason WP,Van Den Bent Mj,et al.Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma[J].N Engl J Med,2005,352:987-996.
8Immon A,Vapalahti M,Tyynela K,et al.AdvHSK-tk gene therapy with intravenous Ganciclovir improves survival in human malignant glioma:a randomized controlled study[J].Mol Ther,2004,10:967-972.
9Byrne TN.Response of low-grade oligodendroglial tumors to temozolomide[J].J Neurooncol,2004,70(3):279-280.
10Cairncross JG,Ueki K,Zlatescu MC,et al.Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligdendroglioma[J].J Natl Cancer Inst,1998,90(19):1473-1479.
